Share Prices & Company Research

Market News

19 Mar 2021 | 12:26

Futura's topical erection gel recommended for EU approval

(Sharecast News) - Pharmaceuticals company Futura Medical said on Friday that the relevant EU notified body has completed the review of its technical dossier for 'MED3000', with a recommendation to certificate MED3000 as a class 2B approved medical device. The AIM-traded firm said once the certificate was received, its MED3000 topical gel formulation would become the first pan-European topical treatment for erectile dysfunction, available without a doctor's prescription.

Once EU certification and the resultant CE-mark is granted, the board said it would be able to seek "rapid approval" in a number of countries around the world, in regions including the Middle East, Africa, the Far East and Latin America, where 'fast-track' review was permitted based on recognition of the CE mark.

The CE marking would also be recognised in the United Kingdom market until 30 June, and in the period leading up to that, the company said it would secure the new post-Brexit UKCA mark.

That would also be a streamlined process, as it was understood the UK application could bridge to the EU approval.

"The recommendation to approve MED3000 in Europe is a huge milestone for Futura in the development of MED3000," said chief executive officer James Barder.

"We look forward with excitement to bringing MED3000 to patients in Europe as the first, clinically proven treatment for erectile dysfunction that is highly differentiated with its rapid speed of onset.

"Once the certificate is issued, MED3000 may be marketed throughout the EU without the need of a doctor's prescription subject to any national marketing restrictions."

At the close on Friday, shares in Futura Medical were up 172.22% at 49p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.